Trial NCT02577029

View at ClinicalTrials.gov 
Org. Study IDs: Heparc-2008
Secondary IDs: 2015-005499-46

Last trial update was posted on 2019-04-12

MeSH Interventions

Entecavir Histamine Antagonists Histamine H1 Antagonists Interferon alpha-2 Interferon-alpha Interferons Peginterferon alfa-2a Tenofovir

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic Hepatitis D

Other Conditions


Stopping Reasons

Company decision to discontinue trial

Limitations And Caveats

The ARC-520 Injection development program was terminated early for regulatory and business reasons secondary to findings occurring in a non-clinical toxicology study. Program termination was not due to safety findings in humans.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID